Literature DB >> 8009877

Experience with macroscopic vasectomy reversal at the Medical College of Wisconsin.

D M Dewire1, R K Lawson.   

Abstract

Thirty-two men underwent vasectomy reversal using loupe magnification at the Medical College of Wisconsin between 1984 and 1991. Semen analysis and pregnancy data were available for 27 of them, and sperm were present in the ejaculate of 24, representing a patency rate of 89%. Pregnancy was established by 11, for a pregnancy rate of 41%. These results suggest that vasovasostomy using loupe magnification provides acceptable rates of patency and pregnancy, although the pregnancy rate appears to be somewhat lower than that reported for microsurgical repair. The lower cost of macroscopic vasectomy reversal may outweigh the potential statistical advantages for some couples.

Entities:  

Keywords:  Americas; Developed Countries; Family Planning; Microsurgery; North America; Northern America; Reversible Sterilization; Sterilization Reversal--men; Sterilization, Sexual; Surgery; Treatment; United States; Vas Reanastomosis; Wisconsin

Mesh:

Year:  1994        PMID: 8009877

Source DB:  PubMed          Journal:  Wis Med J        ISSN: 0043-6542


  4 in total

Review 1.  Surgical techniques for the management of male infertility.

Authors:  Natalya A Lopushnyan; Thomas J Walsh
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

Review 2.  Reversal of vasectomy using a macroscopic technique: a retrospective study.

Authors:  R G Mason; P G Connell; J C Bull
Journal:  Ann R Coll Surg Engl       Date:  1997-11       Impact factor: 1.891

3.  Impact of surgical volume and resident involvement on patency rates after vasectomy reversal-A 14-year experience in an open access system.

Authors:  Alexandria M Hertz; Andrew W Stamm; Mark I Anderson; Karen C Baker
Journal:  Asian J Urol       Date:  2020-04-23

Review 4.  Obstructive azoospermia: reconstructive techniques and results.

Authors:  Karen Baker; Edmund Sabanegh
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.